Company / R&D Expense
Apyx Medical Corp R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.4M
FY2025
5-year range
$3.4M / $5.1M
FY2021-FY2025
Trend
-33.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $1M in FY2018 to $5M in FY2024.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -2.0%.
Declined from $5M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -2.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.0%, indicating a declining trend.
- In FY2025, r&d expense decreased 33.6% year-over-year.
- Peak r&d expense was recorded in FY2024.
- Lowest r&d expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4M | -33.6% |
| FY2024 | $5.1M | +11.8% |
| FY2023 | $4.5M | +0.0% |
| FY2022 | $4.5M | +15.9% |
| FY2021 | $3.9M | +5.1% |
| FY2020 | $3.7M | +92.2% |
| FY2019 | $1.9M | +87.9% |
| FY2018 | $1.0M | -52.2% |
| FY2017 | $2.2M | +52.5% |
| FY2016 | $1.4M | +12.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026